Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

634 ARTÍCULOS , VIENDO DEL 316 AL 330

Exploring Adjunctive Novel Therapeutic Approach of KarXT (Xanomeline-Trospium Chloride) for Managing Psychotic Symptoms in Patients With Schizophrenia and Alzheimer's Disease

Kanwal A, Azeem B, Nasir H, Mumtaz F, Ashraf N, Amin MHJ, Kanwal W, Khan BW.

Brain Behav. 2026 Jan;16(1):e71182. doi: 10.1002/brb3.71182.

Evaluating senescence-targeted approaches in Alzheimer's Disease: What we know and what lies ahead

Doshi PP, Desale SH, Khutale AA, Sabarathinam S, Suresh S.

Ageing Res Rev. 2026 Mar;115:103029. doi: 10.1016/j.arr.2026.103029. Epub 2026 Jan 19.

Unmasking the hidden catalyst: How infections trigger Alzheimer's disease

Fulop T, Cohen AA, Frost EH, Lévesque S, Khalil A, Rodrigues S, Desroches M, Alami M, Berrougui H, Ramassamy C, Hirokawa K, Witkowski JM, Laurent B.

J Alzheimers Dis. 2026 Mar;110(2):519-536. doi: 10.1177/13872877251415571. Epub 2026 Jan 27.

Apolipoprotein E4 in Alzheimer's Disease: Role in Pathology, Lipid Metabolism, and Drug Treatment

Al-Ghraiybah NF, Alkhalifa AE, Itokazu Y, Farr TO, Perez NC, Ali H, Kaddoumi A.

Int J Mol Sci. 2026 Jan 19;27(2):1004. doi: 10.3390/ijms27021004.

Neuroinflammation as a Central Mechanism in Alzheimer's Disease: Therapeutic Insights from Schiff Base Derivatives

Abdullah SK, See-Too WS, Mohd Mohidin TB, Mohan G.

Molecules. 2026 Jan 29;31(3):465. doi: 10.3390/molecules31030465.

Recent Advances in Polyoxometalates Targeting Proteins Associated with Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Applications

Zhang L, Lu T, Hua Z, Peng S, Du H, Zhai X, Cai Z, Hua J, Ma X.

Int J Mol Sci. 2026 Jan 27;27(3):1257. doi: 10.3390/ijms27031257.

Harnessing estrogen's neuroprotective potential in mitigating Alzheimer's pathologies in postmenopausal women: a review

Manasa M, Bethanagere Ramesha G, Krishna KL, Ambika MS, Nadig APR, Pathak S, Jalawadi P.

Brain Res. 2026 May 15;1879:150226. doi: 10.1016/j.brainres.2026.150226. Epub 2026 Feb 21.

Taurine as an Early-Phase Disease-Modifying Candidate for Alzheimer's Disease

Hossain MK, Kim HR.

Int J Mol Sci. 2026 Feb 15;27(4):1871. doi: 10.3390/ijms27041871.

Advances in Immune Cell Interactions and Natural Compounds Therapeutic Strategies in Alzheimer's Disease

Zhou S, Xu L, Dong J, Zhang X, Gao W, Luo H, Fang X.

Phytother Res. 2026 Apr;40(4):1837-1861. doi: 10.1002/ptr.70249. Epub 2026 Feb 2.

Targeting microglia-mediated neuroinflammation in Alzheimer's disease: mechanisms and therapeutic approaches

Li BF, Chen XY, Xie R, Mo YF, Wu YZ, Meng Y, Han XL, Chen MH, Peng YJ.

Front Immunol. 2026 May 13;17:1818802. doi: 10.3389/fimmu.2026.1818802. eCollection 2026.

The Role and Molecular Mechanism of Icaritin in the Treatment of Alzheimer's Disease

Zheng CB, Wu LZ, Song WY, Luo L, Cai JT, Huang ZH, Tian KQ.

Curr Med Chem. 2026;33(3):605-615. doi: 10.2174/0109298673354454250124074057.

The Potential of Coenzyme Q10 in Alzheimer's Disease: Reducing IL-17 Induced Inflammation and Oxidative Stress for Neuroprotection

Sharma H, Binte Ibrahim S, Al Noman A, Zohora UFT, Shifa FA, Siddika S, Tasneem S, Al Azad M, Pathak R.

Curr Drug Res Rev. 2026;18(1):92-105. doi: 10.2174/0125899775373406250411104442.

Targeting Microglial Phagocytosis for Alzheimer's Disease Management: Natural, Pharmacological, Nanoparticle, and Gene Therapy Approaches

Raghuvanshi S, Mazumder A, Das S.

CNS Neurol Disord Drug Targets. 2026;25(1):1-24. doi: 10.2174/0118715273378092250623064748.

Recent Advances of the Role of Dl-3-n-Butylphthalide in the Treatment of Alzheimer's Disease

Huang H, Wu J, Fang Z, Wang Y, Xie J, Guan Y.

Mol Neurobiol. 2026 Jan 3;63(1):340. doi: 10.1007/s12035-025-05616-8.

Challenges and Opportunities of Drug Delivery for Treatment of Alzheimer's Disease

Abd El-Fattah MA.

AAPS PharmSciTech. 2026 Jan 15;27(1):78. doi: 10.1208/s12249-025-03316-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias